Scientists Create Blood Vessels, Capillaries for Lab-Grown Tissues
|
By LabMedica International staff writers Posted on 07 Feb 2011 |
Researchers have overcome one of the major hurdles on the path to growing transplantable tissue in the lab: they have found a way to grow the blood vessels and capillaries needed to keep tissues alive.
The new research, conducted by investigators from Rice University (Houston, TX, USA) and Baylor College of Medicine (BCM; Houston, TX, USA), is available online, and it was published in the January 2011 issue of the journal Acta Biomaterialia. "The inability to grow blood-vessel network --or vasculature--in lab-grown tissues is the leading problem in regenerative medicine today,” said lead coauthor Dr. Jennifer West, department chair, and professor of bioengineering at Rice. "If you don't have blood supply, you cannot make a tissue structure that is thicker than a couple hundred microns.”
As its base material, a team of researchers led by Dr. West and BCM molecular physiologist Dr. Mary Dickinson chose polyethylene glycol (PEG), a nontoxic plastic that is widely used in medical devices and food. Building on 10 years of research in Dr. West's lab, the scientists modified the PEG to mimic the body's extracellular matrix--the network of proteins and polysaccharides that comprise a considerable portion of most tissues.
Drs. West, Dickinson, Rice graduate student Jennifer Saik, Rice, undergraduate Emily Watkins, and Rice-BCM graduate student Daniel Gould combined the modified PEG with two kinds of cells--both of which are needed for blood-vessel formation. Using light that locks the PEG polymer strands into a solid gel, they created soft hydrogels that contained living cells and growth factors. After that, they filmed the hydrogels for 72 hours. By tagging each type of cell with a different colored fluorescent marker, the scientists were able to see as the cells gradually formed capillaries throughout the soft, plastic gel.
To assess these new vascular networks, the researchers implanted the hydrogels into the corneas of mice, where no natural vasculature exists. After injecting a dye into the mice's bloodstream, the researchers confirmed normal blood flow in the newly grown capillaries.
Another major development, conducted by Dr. West and graduate student Joseph Hoffmann, in November 2010, involved the generation of a new technique called two-photon lithography, an ultrasensitive method of using light to create intricate three-dimensional (3D) patterns within the soft PEG hydrogels. West said the patterning technique allows the engineers to exert a fine level of control over where cells move and grow. In follow-up research, also in collaboration with the Dickinson lab at BCM, Dr. West and her colleagues plan to use the technique to grow blood vessels in predetermined patterns.
Related Links:
Rice University
Baylor College of Medicine
The new research, conducted by investigators from Rice University (Houston, TX, USA) and Baylor College of Medicine (BCM; Houston, TX, USA), is available online, and it was published in the January 2011 issue of the journal Acta Biomaterialia. "The inability to grow blood-vessel network --or vasculature--in lab-grown tissues is the leading problem in regenerative medicine today,” said lead coauthor Dr. Jennifer West, department chair, and professor of bioengineering at Rice. "If you don't have blood supply, you cannot make a tissue structure that is thicker than a couple hundred microns.”
As its base material, a team of researchers led by Dr. West and BCM molecular physiologist Dr. Mary Dickinson chose polyethylene glycol (PEG), a nontoxic plastic that is widely used in medical devices and food. Building on 10 years of research in Dr. West's lab, the scientists modified the PEG to mimic the body's extracellular matrix--the network of proteins and polysaccharides that comprise a considerable portion of most tissues.
Drs. West, Dickinson, Rice graduate student Jennifer Saik, Rice, undergraduate Emily Watkins, and Rice-BCM graduate student Daniel Gould combined the modified PEG with two kinds of cells--both of which are needed for blood-vessel formation. Using light that locks the PEG polymer strands into a solid gel, they created soft hydrogels that contained living cells and growth factors. After that, they filmed the hydrogels for 72 hours. By tagging each type of cell with a different colored fluorescent marker, the scientists were able to see as the cells gradually formed capillaries throughout the soft, plastic gel.
To assess these new vascular networks, the researchers implanted the hydrogels into the corneas of mice, where no natural vasculature exists. After injecting a dye into the mice's bloodstream, the researchers confirmed normal blood flow in the newly grown capillaries.
Another major development, conducted by Dr. West and graduate student Joseph Hoffmann, in November 2010, involved the generation of a new technique called two-photon lithography, an ultrasensitive method of using light to create intricate three-dimensional (3D) patterns within the soft PEG hydrogels. West said the patterning technique allows the engineers to exert a fine level of control over where cells move and grow. In follow-up research, also in collaboration with the Dickinson lab at BCM, Dr. West and her colleagues plan to use the technique to grow blood vessels in predetermined patterns.
Related Links:
Rice University
Baylor College of Medicine
Latest BioResearch News
- Immune Biomarkers Support Early Risk Stratification in Oral Precancer
- Global Genetic Map Identifies Regional Parkinson’s Variants to Support Diagnostics
- Breakthrough Genetic Map Advances Understanding of Bone Disorders
- Study Identifies Hereditary Subtype of Aggressive Prostate Cancer
- Gene Variants Linked to Pollution-Exacerbated Asthma
- Single-Cell Analysis Mapping Links Inflammation Response to Acute Myeloid Leukemia
- Study Reveals New Insights into Rare Blood Cancer Development
- New Findings Clarify Molecular Drivers of Rare Small Intestinal Cancer
- Lung Cancer Study Reveals Cellular Program Behind Therapy Resistance
- Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers
- Lysosomal Gene Defect Linked to Severe Childhood Brain Disorders
- Genetic Testing Identifies Greater Inherited Sudden Cardiac Arrest Risk in Younger Individuals
- Hidden 'Jumping Gene' Variant Linked to Higher Pancreatic Cancer Risk
- Common White Blood Cells Produce Schizophrenia-Linked Protein
- Nanopore Method Captures RNA Folding at Single-Molecule Resolution
- Tumor Microenvironment Marker Linked to Worse Survival in Solid Tumors
Channels
Clinical Chemistry
view channel
New Machine-Learning Equation Improves LDL Cholesterol Assessment
Accurate assessment of low-density lipoprotein (LDL) cholesterol is central to cardiovascular risk management, yet calculation methods can underestimate values in some patients. Laboratories widely use... Read more
Blood Biomarker May Signal Cognitive Decline Risk a Decade Before Symptoms
Accurately identifying which cognitively healthy older adults will later develop impairment due to Alzheimer’s disease remains difficult, as brain scans and genetic testing provide only part of the risk picture.... Read moreMolecular Diagnostics
view channel
New Biomarker Helps Guide Combination Therapy for Treatment-Resistant Breast Cancer
Chemotherapy resistance hampers treatment of triple-negative breast cancer (TNBC), particularly in tumors with TP53 mutations. Identifying biomarkers that signal resistance while pointing to actionable... Read moreBlood-Based Gene Expression Test Detects Early Pancreatic Cancer
Pancreatic cancer remains difficult to detect at a curable stage and is associated with poor survival outcomes. In Japan, the five-year relative survival rate is 8.5%, while early-stage disease accounts... Read moreHematology
view channel
New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more
AI Decision Support System Guides Treatment Selection for Complex Blood Cancers
Treatment selection for hematologic malignancies often requires clinicians to synthesize clinical histories, genomic alterations, prior therapies, and rapidly evolving drug options. These complex decisions... Read moreImmunology
view channel
New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
Eurofins Viracor has introduced three plasma-based assays—CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and interleukin-18 (IL-18) (Test Code 33611)—expanding its immunology testing menu for transplant... Read more
Cell-Free Assay Detects Functional IgE for Food Allergy Diagnosis
Accurately distinguishing sensitization from clinically relevant food allergy remains a challenge for laboratories, as routine blood tests detect allergen-specific immunoglobulin E (IgE) but not its capacity... Read more
Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19
Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more
Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms
Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read moreMicrobiology
view channel
Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
U.S. health authorities have reported a rapid increase in cyclosporiasis since May 2026, with more than 1,600 confirmed infections and thousands of additional suspected cases under investigation.... Read more
Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections
Bloodstream infections require rapid identification of causative pathogens and resistance mechanisms to guide effective therapy. Delays in profiling gram-negative organisms, which are frequently associated... Read morePathology
view channel
AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity
Myelodysplastic neoplasms, a group of blood cancers that primarily affect older adults, are challenging to stage and monitor, often requiring repeated bone marrow biopsies that can yield uncertain interpretations.... Read more
Imaging Platform Maps Lipid Accumulations in Fabry Heart Tissue
Mapping the spatial distribution of disease-relevant molecules within tissue remains a diagnostic challenge, particularly before alterations are visible by conventional microscopy. In Fabry disease, a... Read moreTechnology
view channel
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channel
Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition
Leica Biosystems, an operating company of Danaher, has entered into a definitive agreement to acquire privately held StatLab Medical Products from Linden Capital Partners and Audax Private Equity.... Read more




.jpg)



